Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lucinda A. Harris & Noemi Baffy. (2017) Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgraduate Medicine 129:8, pages 872-888.
Read now
Read now
Luise Mølenberg Begtrup, Ove B Schaffalitzky de Muckadell, Jens Kjeldsen, René dePont Christensen & Dorte Ejg Jarbøl. (2013) Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 48:10, pages 1127-1135.
Read now
Read now
Simone Maccaferri, Marco Candela, Silvia Turroni, Manuela Centanni, Marco Severgnini, Clarissa Consolandi, Piero Cavina & Patrizia Brigidi. (2012) IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbes 3:5, pages 406-413.
Read now
Read now
Ron Schey & Satish SC Rao. (2011) The role of rifaximin therapy in patients with irritable bowel syndrome without constipation. Expert Review of Gastroenterology & Hepatology 5:4, pages 461-464.
Read now
Read now
Kristian Bjøro. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:6, pages 643-644.
Read now
Read now
C Stevenson & R Blaauw. (2011) Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 24:2, pages 63-71.
Read now
Read now
Articles from other publishers (53)
S. V. Belmer. (2023) Irritable bowel syndrome in children and intestinal microbiota: pathogenetic aspects and clinical guidelines. Meditsinskiy sovet = Medical Council:17, pages 143-148.
Crossref
Crossref
Min Chen, Lu Yuan, Chao-Rong Xie, Xiao-Ying Wang, Si-Jia Feng, Xin-Yu Xiao & Hui Zheng. (2023) Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis. International Journal of Surgery 109:11, pages 3631-3647.
Crossref
Crossref
Peiwei Xie, Mei Luo, Xuehong Deng, Jiahui Fan & Lishou Xiong. (2023) Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 15:17, pages 3856.
Crossref
Crossref
S. V. Belmer, M. M. Gurova, A. A. Zvyagin, E. A. Kornienko, A. V. Nalyotov, A. A. Nizhevich, V. P. Novikova, D. V. Pechkurov, V. F. Privorotskii, A. A. Tyazheva, R. A. Faizullina & A. I. Khavkin. (2023) Irritable bowel syndrome in children: evolution of manifestations. Experimental and Clinical Gastroenterology 1:1, pages 98-107.
Crossref
Crossref
Harmandeepsingh Lamsar & Abhilasha Abhilasha. 2023. Industrial Application of Functional Foods, Ingredients and Nutraceuticals. Industrial Application of Functional Foods, Ingredients and Nutraceuticals
127
170
.
Tao Zhang, Cunzheng Zhang, Jindong Zhang, Feng Sun & Liping Duan. (2022) Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Chao-Rong Xie, Bin Tang, Yun-Zhou Shi, Wen-Yan Peng, Kun Ye, Qing-Feng Tao, Shu-Guang Yu, Hui Zheng & Min Chen. (2022) Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Lynne V. McFarland, Tarkan Karakan & Ali Karatas. (2021) Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 41, pages 101154.
Crossref
Crossref
Agnieszka Chlebicz-Wójcik & Katarzyna Śliżewska. (2021) Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Biomolecules 11:8, pages 1154.
Crossref
Crossref
Xingzhu Yuan, Chengting Chang, Xinrong Chen & Ka Li. (2021) Emerging trends and focus of human gastrointestinal microbiome research from 2010–2021: a visualized study. Journal of Translational Medicine 19:1.
Crossref
Crossref
Dennis A Savaiano & Robert W Hutkins. (2021) Yogurt, cultured fermented milk, and health: a systematic review. Nutrition Reviews 79:5, pages 599-614.
Crossref
Crossref
Bing Li, Li Liang, Huijie Deng, Jinmin Guo, He Shu & Li Zhang. (2020) Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Heng-Li Niu & Ji-Yuan Xiao. (2020) The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 75, pages 116-127.
Crossref
Crossref
Nasim Khorshidian, Mojtaba Yousefi & Amir M. Mortazavian. 2020. Probiotic and Prebiotics in Foods: Challenges, Innovations and Advances. Probiotic and Prebiotics in Foods: Challenges, Innovations and Advances
91
114
.
Tanima Jana, Brent W. Acker & Brooks D. Cash. 2020. Clinical and Basic Neurogastroenterology and Motility. Clinical and Basic Neurogastroenterology and Motility
587
600
.
Ding Liang, Ning Longgui & Xu Guoqiang. (2019) Efficacy of different probiotic protocols in irritable bowel syndrome. Medicine 98:27, pages e16068.
Crossref
Crossref
Ruqiao DuanShiwei ZhuBen WangLiping Duan. (2019) Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review. Clinical and Translational Gastroenterology 10:2, pages e00012.
Crossref
Crossref
Alexander C. Ford, Lucinda A. Harris, Brian E. Lacy, Eamonn M. M. Quigley & Paul Moayyedi. (2018) Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 48:10, pages 1044-1060.
Crossref
Crossref
Jin Young Yoon, Jae Myung Cha, Ju Kyoung Oh, Pei Lei Tan, Sae Hun Kim, Min Seob Kwak, Jung Won Jeon & Hyun Phil Shin. (2018) Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study. Digestive Diseases and Sciences 63:10, pages 2754-2764.
Crossref
Crossref
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy & Gerard E. Mullin. (2018) The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 19:3, pages 136-141.
Crossref
Crossref
L. Laterza, G. Gibiino, F. Scaldaferri & A. Gasbarrini. (2018) Benefits of multistrain bacteria formulations for health. Journal of Functional Foods 47, pages 531-546.
Crossref
Crossref
Alexander C. Ford, Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito & Eamonn M. M. Quigley. (2018) American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 113, pages 1-18.
Crossref
Crossref
A. P. S. Hungin, C. R. Mitchell, P. Whorwell, C. Mulligan, O. Cole, L. Agréus, P. Fracasso, C. Lionis, J. Mendive, J.‐M. Philippart de Foy, B. Seifert, K.‐A. Wensaas, C. Winchester & N. de Wit. (2018) Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus. Alimentary Pharmacology & Therapeutics 47:8, pages 1054-1070.
Crossref
Crossref
W.-T. Fan, C. Ding, N.-N. Xu, S. Zong, P. Ma & B. Gu. (2017) Close association between intestinal microbiota and irritable bowel syndrome. European Journal of Clinical Microbiology & Infectious Diseases 36:12, pages 2303-2317.
Crossref
Crossref
Jian Zhang, Chunying Wang, Ji Wang & Fengchi Zhang. (2017) Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Jonna Jalanka & Robin Spiller. (2017) Role of microbiota in the pathogenesis of functional disorders of the lower GI tract: Work in progress. Neurogastroenterology & Motility 29:10, pages e13194.
Crossref
Crossref
Hyo Jeong Lee, Jong Kyoung Choi, Han Seung Ryu, Chang Hwan Choi, Eun Hee Kang, Kyung Sik Park, Yang Won Min & Kyoung Sup Hong. (2017) Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. Journal of Neurogastroenterology and Motility 23:1, pages 9-19.
Crossref
Crossref
A. Benítez-Páez & Y. Sanz. 2017. Fermented Foods in Health and Disease Prevention. Fermented Foods in Health and Disease Prevention
159
172
.
Y. A. McKenzie, J. Thompson, P. Gulia & M. C. E. Lomer. (2016) British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 29:5, pages 576-592.
Crossref
Crossref
Y. A. McKenzie, R. K. Bowyer, H. Leach, P. Gulia, J. Horobin, N. A. O'Sullivan, C. Pettitt, L. B. Reeves, L. Seamark, M. Williams, J. Thompson & M. C. E. Lomer. (2016) British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 29:5, pages 549-575.
Crossref
Crossref
Juan R. Malagelada & Carolina Malagelada. (2016) Mechanism-Oriented Therapy of Irritable Bowel Syndrome. Advances in Therapy 33:6, pages 877-893.
Crossref
Crossref
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci & Stefano Fiorucci. (2016) Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 22:7, pages 2219-2241.
Crossref
Crossref
Z. Mujagic, D. Keszthelyi, Q. Aziz, W. Reinisch, E. G. Quetglas, F. De Leonardis, M. Segerdahl & A. A. M. Masclee. (2015) Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 42:9, pages 1064-1081.
Crossref
Crossref
Nazar Mazurak, Ellen Broelz, Martin Storr & Paul Enck. (2015) Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?. Journal of Neurogastroenterology and Motility 21:4, pages 471-485.
Crossref
Crossref
Anastasia I. Petra, Smaro Panagiotidou, Erifili Hatziagelaki, Julia M. Stewart, Pio Conti & Theoharis C. Theoharides. (2015) Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clinical Therapeutics 37:5, pages 984-995.
Crossref
Crossref
Tina Didari. (2015) Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 21:10, pages 3072.
Crossref
Crossref
Antonieta R. Santos & P. J. Whorwell. (2014) Irritable bowel syndrome: the problem and the problem of treating it – is there a role for probiotics?. Proceedings of the Nutrition Society 73:4, pages 470-476.
Crossref
Crossref
Alexander C Ford, Eamonn M M Quigley, Brian E Lacy, Anthony J Lembo, Yuri A Saito, Lawrence R Schiller, Edy E Soffer, Brennan M R Spiegel & Paul Moayyedi. (2014) Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. American Journal of Gastroenterology 109:10, pages 1547-1561.
Crossref
Crossref
Luis Vitetta, Rachel Manuel, Joyce Zhou, Anthony Linnane, Sean Hall & Samantha Coulson. (2014) The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals 7:9, pages 954-989.
Crossref
Crossref
Alexander C Ford, Paul Moayyedi, Brian E Lacy, Anthony J Lembo, Yuri A Saito, Lawrence R Schiller, Edy E Soffer, Brennan M R Spiegel & Eamonn M M Quigley. (2014) American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. American Journal of Gastroenterology 109, pages S2-S26.
Crossref
Crossref
Brian E. Lacy & Tracia OʼShana. (2014) Clinical Pearls for Irritable Bowel Syndrome. Gastroenterology Nursing 37:6, pages 392-405.
Crossref
Crossref
A. P. S. Hungin, C. Mulligan, B. Pot, P. Whorwell, L. Agréus, P. Fracasso, C. Lionis, J. Mendive, J.-M. Philippart de Foy, G. Rubin, C. Winchester & N. de Wit. (2013) Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide. Alimentary Pharmacology & Therapeutics 38:8, pages 864-886.
Crossref
Crossref
Michel Dapoigny. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome
141
158
.
P. Marteau, D. Guyonnet, P. Lafaye de Micheaux & S. Gelu. (2013)
A randomized, double‐blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic
Bifidobacterium lactis
CNCM I‐2494 in healthy women reporting minor digestive symptoms
. Neurogastroenterology & Motility 25:4, pages 331.
Crossref
Crossref
Eamonn M.M. Quigley. (2012) Probiotics in the Management of Functional Bowel Disorders. Gastroenterology Clinics of North America 41:4, pages 805-819.
Crossref
Crossref
Maya Balakrishnan & Martin H. Floch. (2012) Prebiotics, probiotics and digestive health. Current Opinion in Clinical Nutrition and Metabolic Care 15:6, pages 580-585.
Crossref
Crossref
A. L. Engsbro, M. Simrén & P. Bytzer. (2012) The Rome II and Rome III criteria identify the same subtype‐populations in irritable bowel syndrome: agreement depends on the method used for symptom report. Neurogastroenterology & Motility 24:7, pages 604.
Crossref
Crossref
A. de los Santos Moreno, P. Romero Cores, F. Navarro & J.A. Girón González. (2012) Síndrome de malabsorción (II). Enfermedad celiaca. Intolerancia a la lactosa. Sobrecrecimiento bacteriano. Medicine - Programa de Formación Médica Continuada Acreditado 11:4, pages 206-213.
Crossref
Crossref
G. Clarke, J. F. Cryan, T. G. Dinan & E. M. Quigley. (2012) Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Alimentary Pharmacology & Therapeutics 35:4, pages 403-413.
Crossref
Crossref
A. L. Engsbro, M. Simren & P. Bytzer. (2011) Short‐term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Alimentary Pharmacology & Therapeutics 35:3, pages 350-359.
Crossref
Crossref
Shen-Shih Chiang & Tzu-Ming Pan. (2011) Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products. Applied Microbiology and Biotechnology 93:3, pages 903-916.
Crossref
Crossref
Ian M. Carroll, Tamar Ringel-KulkaTemitope O. Keku, Young-Hyo Chang, Christopher D. PackeyR. Balfour Sartor & Yehuda Ringel. (2011) Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 301:5, pages G799-G807.
Crossref
Crossref
Lynne Vernice McFarland, Tarkan Karatas & Ali Karatas. (2021) Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref